Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Recruiting · NCT06680752 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-12-10 | NCT06680752 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ARCE Therapeutics, Inc. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Novant Health Cancer Institute | Charlotte | United States | 8 |
| Novant Health Cancer Institute | Winston-Salem | United States | 2 |